We are live on ! Find out more
CCP

Cryder Capital Partners Portfolio holdings

AUM $1.53B
1-Year Est. Return 9.36%
This Fund
S&P 500
This Quarter Est. Return
+10.95%
1 Year Est. Return
+9.36%
3 Year Est. Return
+71.2%
5 Year Est. Return
+84.02%
10 Year Est. Return
+425.03%
AUM
$171M
AUM Growth
+$46M
Cap. Flow
+$31.5M
Cap. Flow %
18.48%
Top 10 Hldgs %
100%
Holding
10
New
Increased
10
Reduced
Closed

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$6.13M
2
HCA icon
HCA Healthcare
HCA
+$5.87M
3
BFH icon
Bread Financial
BFH
+$3.71M
4
WAB icon
Wabtec
WAB
+$3.36M
5
IQV icon
IQVIA
IQV
+$2.28M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 45.1%
2 Financials 28.15%
3 Communication Services 14.07%
4 Industrials 12.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
1
Thermo Fisher Scientific
TMO
$214B
$26.2M 15.36%
164,704
+39,780
+32% +$6.13M
HCA icon
2
HCA Healthcare
HCA
$92.8B
$23.8M 13.94%
314,531
+76,630
+32% +$5.87M
BFH icon
3
Bread Financial
BFH
$4.36B
$22.4M 13.16%
131,091
+21,802
+20% +$3.71M
WAB icon
4
Wabtec
WAB
$51.7B
$21.6M 12.68%
264,915
+45,750
+21% +$3.36M
IQV icon
5
IQVIA
IQV
$40.5B
$14.5M 8.47%
178,312
+30,100
+20% +$2.28M
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.08T
$13.2M 7.76%
329,200
+55,400
+20% +$2.17M
MA icon
7
Mastercard
MA
$497B
$12.8M 7.5%
125,668
+21,200
+20% +$2.03M
V icon
8
Visa
V
$697B
$12.8M 7.5%
154,638
+26,000
+20% +$2.08M
PRXL
9
DELISTED
Parexel International Corp
PRXL
$12.5M 7.34%
180,206
+31,300
+21% +$2.11M
GOOG icon
10
Alphabet (Google) Class C
GOOG
$4.07T
$10.8M 6.31%
277,180
+47,000
+20% +$1.78M

Similar funds

Cryder Capital Partners's Q3 2016 Portfolio in Review

As of Q3 2016, Cryder Capital Partners held 10 positions worth $171M, up 37% from $125M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Cryder Capital Partners deployed $31.5M of net new capital in Q3 2016, adding to 10 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 45% a quarter earlier, followed by Financials and Communication Services.

  • Cryder Capital Partners added most to Thermo Fisher Scientific in Q3 2016, an estimated $6.13M increase.
  • Cryder Capital Partners's ten largest holdings make up 100% of its $171M portfolio in Q3 2016.
  • Cryder Capital Partners opened 0 new positions and closed 0 in Q3 2016.
  • Cryder Capital Partners's portfolio value rose 37% quarter-over-quarter to $171M.

Based on Cryder Capital Partners's 13F filing for Q3 2016, filed 3 Nov 2016.